This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stevens, M. G. Articles by Brees, D. Search for Related Content PubMed PubMed Citation Articles by Stevens, M. G. Articles by Brees, D.

 Previous Article  |  Next Article 

Infect. Immun., Jan 1995, 264-270, Vol 63, No. 1
Copyright © 1995, American Society for Microbiology

Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51

MG Stevens, SC Olsen, GW Pugh Jr and D Brees
Brucellosis Research Unit, National Animal Disease Center, Agriculture Research Service, U.S. Department of Agriculture, Ames, Iowa 50010.

Immune responses and resistance to infection with Brucella abortus 2308 (S2308) were measured in mice following vaccination with B. abortus 19 (S19) or the lipopolysaccharide (LPS) O-antigen-deficient mutant, strain RB51 (SRB51). Live bacteria persisted for 8 weeks in spleens of mice vaccinated with 5 x 10(6) or 5 x 10(8) CFU of SRB51, whereas bacteria persisted for 12 weeks in mice vaccinated with 5 x 10(6) CFU of S19. Mice vaccinated with 5 x 10(6) or 5 x 10(8) CFU of SRB51 had increased resistance to infection with S2308 at 12, 16, and 20 weeks after vaccination, but the resistance was lower than that induced by vaccinating mice with 5 x 10(6) CFU of S19. Spleen cells obtained from mice vaccinated with S19 or SRB51 generally exhibited similar proliferative responses to S2308 bacteria or bacterial proteins (106 to 18 kDa) following challenge of mice with S2308 at 12, 16, or 20 weeks after vaccination. Mice vaccinated with S19 had antibody to S2308 bacteria and S2308 smooth LPS at 4, 8, and 12 weeks after vaccination. In contrast, mice vaccinated with either dose of SRB51 did not produce antibody to S2308 smooth LPS. In addition, only mice vaccinated with the highest dose of SRB51 (5 x 10(8) CFU) had antibody responses to S2308 bacteria, although the responses were lower and less persistent than those in mice vaccinated with S19. Collectively, these results indicate that SRB51-vaccinated mice have similar cell-mediated immune responses to S2308 but lower resistance to infection with S2308 compared with S19-vaccinated mice. The lower resistance in SRB51- vaccinated mice probably resulted from a combination of rapid clearance of SRB51 and an absence of antibodies to S2308 LPS.

This article has been cited by other articles:

• Arenas-Gamboa, A. M., Ficht, T. A., Kahl-McDonagh, M. M., Rice-Ficht, A. C. (2008). Immunization with a Single Dose of a Microencapsulated Brucella melitensis Mutant Enhances Protection against Wild-Type Challenge. Infect. Immun. 76: 2448-2455 [Abstract] [Full Text]  
• Campos, M. A., Rosinha, G. M. S., Almeida, I. C., Salgueiro, X. S., Jarvis, B. W., Splitter, G. A., Qureshi, N., Bruna-Romero, O., Gazzinelli, R. T., Oliveira, S. C. (2004). Role of Toll-Like Receptor 4 in Induction of Cell-Mediated Immunity and Resistance to Brucella abortus Infection in Mice. Infect. Immun. 72: 176-186 [Abstract] [Full Text]  
• Monreal, D., Grillo, M. J., Gonzalez, D., Marin, C. M., De Miguel, M. J., Lopez-Goni, I., Blasco, J. M., Cloeckaert, A, Moriyon, I. (2003). Characterization of Brucella abortus O-Polysaccharide and Core Lipopolysaccharide Mutants and Demonstration that a Complete Core Is Required for Rough Vaccines To Be Efficient against Brucella abortus and Brucella ovis in the Mouse Model. Infect. Immun. 71: 3261-3271 [Abstract] [Full Text]  
• Pasquali, P., Rosanna, A., Pistoia, C., Petrucci, P., Ciuchini, F. (2003). Brucella abortus RB51 Induces Protection in Mice Orally Infected with the Virulent Strain B. abortus 2308. Infect. Immun. 71: 2326-2330 [Abstract] [Full Text]  
• Tavares, D., Ferreira, P., Arala-Chaves, M. (2003). Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein. Microbiology 149: 333-339 [Abstract] [Full Text]  
• Ko, J., Splitter, G. A. (2003). Molecular Host-Pathogen Interaction in Brucellosis: Current Understanding and Future Approaches to Vaccine Development for Mice and Humans. Clin. Microbiol. Rev. 16: 65-78 [Abstract] [Full Text]  
• Rosinha, G. M. S., Freitas, D. A., Miyoshi, A., Azevedo, V., Campos, E., Cravero, S. L., Rossetti, O., Splitter, G., Oliveira, S. C. (2002). Identification and Characterization of a Brucella abortus ATP-Binding Cassette Transporter Homolog to Rhizobium meliloti ExsA and Its Role in Virulence and Protection in Mice. Infect. Immun. 70: 5036-5044 [Abstract] [Full Text]  
• Pasquali, P., Adone, R., Gasbarre, L. C., Pistoia, C., Ciuchini, F. (2001). Mouse Cytokine Profiles Associated with Brucella abortus RB51 Vaccination or B. abortus 2308 Infection. Infect. Immun. 69: 6541-6544 [Abstract] [Full Text]  
• Onate, A. A., Vemulapalli, R., Andrews, E., Schurig, G. G., Boyle, S., Folch, H. (1999). Vaccination with Live Escherichia coli Expressing Brucella abortus Cu/Zn Superoxide Dismutase Protects Mice against Virulent B. abortus. Infect. Immun. 67: 986-988 [Abstract] [Full Text]  
• Cloeckaert, A., Weynants, V., Godfroid, J., Verger, J.-M., Grayon, M., Zygmunt, M. S. (1998). O-Polysaccharide Epitopic Heterogeneity at the Surface of Brucella spp. Studied by Enzyme-Linked Immunosorbent Assay and Flow Cytometry. CVI 5: 862-870 [Abstract] [Full Text]  
• Iñón de Iannino, N., Briones, G., Tolmasky, M., Ugalde, R. A. (1998). Molecular Cloning and Characterization of cgs, the Brucella abortus Cyclic beta (1-2) Glucan Synthetase Gene: Genetic Complementation of Rhizobium meliloti ndvB and Agrobacterium tumefaciens chvB Mutants. J. Bacteriol. 180: 4392-4400 [Abstract] [Full Text]